{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:51Z","timestamp":1793146611943,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jval.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T18:20:51Z","timestamp":1582741251000},"page":"139-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Value of Information Analysis for Research Decisions\u2014An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force"],"prefix":"10.1016","volume":"23","author":[{"given":"Elisabeth","family":"Fenwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Steuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Knies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ghabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik (Erik)","family":"Koffijberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian D.","family":"Sanders Schmidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rothery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40273-012-0008-3","article-title":"A\u00a0systematic and critical review of the evolving methods and applications of value of information in academia and practice","volume":"31","author":"Steuten","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40273-015-0346-z","article-title":"Use of value of information in healthcare decision making: exploring multiple perspectives","volume":"34","author":"Bindels","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib3","author":"Claxton"},{"key":"10.1016\/j.jval.2020.01.001_bib4","series-title":"Value of information analytical methods: report 2 of the ISPOR value of information analysis emerging good practices task force","author":"Rothery","year":"2020"},{"key":"10.1016\/j.jval.2020.01.001_bib5","series-title":"Probability and Statistics for Business Decisions: An Introduction to Managerial Economics Under Uncertainty","author":"Schlaifer","year":"1959"},{"key":"10.1016\/j.jval.2020.01.001_bib6","series-title":"Applied Statistical Decision Theory","author":"Raiffa","year":"1961"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib7","first-page":"122","article-title":"Information value theory","volume":"2","author":"Howard","year":"1966","journal-title":"IEEE Transact Systems Science and Cybernetics"},{"key":"10.1016\/j.jval.2020.01.001_bib8","series-title":"Decision Analysis: Introductory Lectures on Choices Under Uncertainty","author":"Raiffa","year":"1968"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1086\/258464","article-title":"The economics of information","volume":"69","author":"Stigler","year":"1961","journal-title":"J\u00a0Polit Econ"},{"key":"10.1016\/j.jval.2020.01.001_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","article-title":"The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies","volume":"18","author":"Claxton","year":"1999","journal-title":"J\u00a0Health Econ"},{"key":"10.1016\/j.jval.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-6296(00)00071-0","article-title":"Addressing uncertainty in medical cost-effectiveness analysis. Implications of expected utility maximisation for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research","volume":"20","author":"Meltzer","year":"2001","journal-title":"J\u00a0Health Econ"},{"issue":"11","key":"10.1016\/j.jval.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2165\/00019053-200624110-00003","article-title":"Using value of information analysis to prioritise health research: some lessons from recent UK experience","volume":"24","author":"Claxton","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"29","key":"10.1016\/j.jval.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11290","article-title":"Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses","volume":"11","author":"Colbourn","year":"2007","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1148\/radiol.2533090234","article-title":"Value-of-information analysis to guide future research in colorectal cancer screening","volume":"253","author":"Hassan","year":"2009","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0272989X06297393","article-title":"Value of information on preference heterogeneity and individualized care","volume":"27","author":"Basu","year":"2007","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0272989X15610780","article-title":"A\u00a0framework for prioritizing research investments in precision medicine","volume":"36","author":"Basu","year":"2016","journal-title":"Med Decis Making"},{"issue":"11","key":"10.1016\/j.jval.2020.01.001_bib17","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/hec.3103","article-title":"Valuing trial designs from a pharmaceutical perspective using value based pricing","volume":"24","author":"Breeze","year":"2015","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40258-015-0152-y","article-title":"Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later","volume":"13","author":"Tuffaha","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"issue":"7","key":"10.1016\/j.jval.2020.01.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131255","article-title":"Value of information analysis applied to the economic evaluation of interventions aimed at reducing juvenile delinquency: an illustration","volume":"10","author":"Eeren","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jval.2020.01.001_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0272989X09336142","article-title":"Dimensions of design space: a decision-theoretic approach to optimal research design","volume":"29","author":"Conti","year":"2009","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0272989X09344746","article-title":"Exploring the research decision space: the expected value of information for sequential research designs","volume":"30","author":"Griffin","year":"2010","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0272989X07308751","article-title":"The value of implementation and the value of information: combined and uneven development","volume":"28","author":"Fenwick","year":"2008","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.01.001_bib23","author":"Grimm"},{"key":"10.1016\/j.jval.2020.01.001_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40273-017-0562-9","article-title":"The HTA risk analysis chart: visualizing the need for and potential value of managed entry agreements in health technology assessment","volume":"35","author":"Grimm","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib25","first-page":"A1","article-title":"Value of information methods for optimal timing of biomarker collection","author":"Bansal","year":"2016","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.jval.2020.01.001_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00019053-200826090-00009","article-title":"Subgroups and heterogeneity in cost-effectiveness analysis","volume":"26","author":"Sculpher","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jval.2011.07.015","article-title":"The role of the expected value of individualized care in cost-effectiveness analyses and decision making","volume":"15","author":"van Gestel","year":"2012","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2020.01.001_bib28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0272989X14538705","article-title":"The value of heterogeneity for cost-effectiveness subgroup analysis","volume":"34","author":"Espinoza","year":"2014","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.01.001_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jval.2013.04.011","article-title":"Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force","volume":"16","author":"Garrison","year":"2013","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0272989X16636847","article-title":"Development and evaluation of an approach to using value of information analyses for real-time prioritization decisions within SWOG, a large cancer clinical trials cooperative group","volume":"36","author":"Bennette","year":"2016","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/2381468316642238","article-title":"Value of information analysis informing adoption and research decisions in a portfolio of health care interventions","volume":"1","author":"Tuffaha","year":"2016","journal-title":"MDM Policy & Practice"},{"key":"10.1016\/j.jval.2020.01.001_bib32","series-title":"Systematizing the use of value of information analysis in prioritizing systematic reviews","author":"Hoomans","year":"2012"},{"issue":"4","key":"10.1016\/j.jval.2020.01.001_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/pst.368","article-title":"The rheumatoid arthritis drug development model: a case study in Bayesian clinical trial simulation","volume":"8","author":"Nixon","year":"2009","journal-title":"Pharm Stat"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0272989X15586552","article-title":"Interpretation of the expected value of perfect information and research recommendations: a systematic review and empirical investigation","volume":"36","author":"Thorn","year":"2016","journal-title":"Med Decis Making"},{"issue":"7","key":"10.1016\/j.jval.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0272989X18797948","article-title":"Value of information choices that influence estimates: a systematic review of prevailing considerations","volume":"38","author":"Koffijberg","year":"2018","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.01.001_bib36","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.jval.2020.01.001_bib37","first-page":"377","article-title":"Value of information analysis in healthcare: a review of principles and applications","volume":"17","author":"Tuffaha","year":"2014","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jval.2020.01.001_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2165\/11537370-000000000-00000","article-title":"The value of value of information best informing research design and prioritization using current methods","volume":"28","author":"Eckermann","year":"2010","journal-title":"Pharmacoeconomics"},{"issue":"31","key":"10.1016\/j.jval.2020.01.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8310","article-title":"A\u00a0pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme","volume":"8","author":"Claxton","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2020.01.001_bib40","author":"Myers"},{"issue":"4","key":"10.1016\/j.jval.2020.01.001_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/0272989X13484388","article-title":"Value of information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics","volume":"33","author":"Carlson","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.01.001_bib42","first-page":"A20405","article-title":"Potential value of an aspirin-dose trial for secondary prevention of coronary artery disease: informing PCORI and future trial design","volume":"134","author":"Sanders","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jval.2020.01.001_bib43","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1377\/hlthaff.27.6.1642","article-title":"Evidence-based decision making: when should we wait for more information?","volume":"27","author":"Chalkidou","year":"2008","journal-title":"Health Aff"},{"issue":"46","key":"10.1016\/j.jval.2020.01.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16460","article-title":"Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development","volume":"16","author":"Claxton","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2020.01.001_bib45","author":"Al"},{"key":"10.1016\/j.jval.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/11530850-000000000-00000","article-title":"Access with evidence development schemes: a framework for description and evaluation","volume":"28","author":"McCabe","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11530820-000000000-00000","article-title":"Funding the unfundable: mechanisms for\u00a0managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems","volume":"28","author":"Stafinski","year":"2010","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jval.2011.12.013","article-title":"Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions","volume":"15","author":"Walker","year":"2012","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2020.01.001_bib49","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jval.2015.05.003","article-title":"Unifying research and reimbursement decisions: case studies demonstrating the sequence of assessment and judgments required","volume":"18","author":"McKenna","year":"2015","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/135581969700200107","article-title":"The iterative use of economic evaluation as part of the process of health technology assessment","volume":"2","author":"Sculpher","year":"1997","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.jval.2020.01.001_bib51","author":"Fenwick"},{"key":"10.1016\/j.jval.2020.01.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200523010-00001","article-title":"Role of pharmacoeconomic analysis in R&D decision making. When, where, how?","volume":"23","author":"Miller","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.jval.2020.01.001_bib53","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10198-012-0441-4","article-title":"Targeted screening for coeliac disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information","volume":"14","author":"Mohseninejad","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jval.2014.10.008","article-title":"Evaluation of patient registries supporting reimbursement decisions: the case of oxaliplatin for treatment of stage III colon cancer","volume":"18","author":"Mohseninejad","year":"2015","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2014.145","article-title":"Accelerated access to innovative medicines for patients in need","volume":"96","author":"Baird","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jval.2020.01.001_bib57","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jval.2013.04.013","article-title":"Value of research and value of development in early assessments of new medical technologies","volume":"16","author":"Ret\u00e8l","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.01.001_bib58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0272989X11399921","article-title":"Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis","volume":"31","author":"McKenna","year":"2011","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.jval.2020.01.001_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1137\/120889563","article-title":"When is a model good enough? Deriving the expected value of model improvement via specifying internal model discrepancies","volume":"2","author":"Strong","year":"2014","journal-title":"SIAM\/ASA J Uncertainty Quantification"},{"key":"10.1016\/j.jval.2020.01.001_bib61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40273-016-0381-4","article-title":"Exploring uncertainty in economic evaluations of drugs and medical devices: lessons from the first review of manufacturers\u2019 submissions to the French National Authority for Health","volume":"34","author":"Ghabri","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib62","series-title":"Methods for The Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.jval.2020.01.001_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40273-012-0015-4","article-title":"Acknowledging patient heterogeneity in economic evaluation: a systematic literature review","volume":"31","author":"Grutters","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jval.2012.06.016","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2","volume":"15","author":"Roberts","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.01.001_bib65","series-title":"Uncertain Judgements: Eliciting Experts\u2019 Probabilities","author":"O'Hagan","year":"2006"},{"key":"10.1016\/j.jval.2020.01.001_bib66","article-title":"Eliciting univariate probability distributions","volume":"1","author":"Oakley","year":"2010"},{"key":"10.1016\/j.jval.2020.01.001_bib67","article-title":"Eliciting multivariate probability distributions","volume":"1","author":"Daneshkhah","year":"2010"},{"key":"10.1016\/j.jval.2020.01.001_bib68","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2017"},{"key":"10.1016\/j.jval.2020.01.001_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40273-014-0219-x","article-title":"A\u00a0practical guide to value of information analysis","volume":"33","author":"Wilson","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0272989X07312724","article-title":"The half-life of truth: what are appropriate time horizons for research decisions?","volume":"28","author":"Philips","year":"2008","journal-title":"Med Decis Making"},{"issue":"12","key":"10.1016\/j.jval.2020.01.001_bib71","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/sim.2069","article-title":"The value of information and optimal clinical trial designs","volume":"24","author":"Willan","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2020.01.001_bib72","series-title":"Statistical Analysis of Cost-Effectiveness Data","article-title":"Power and size determination: the value of information approach","author":"Willan","year":"2006"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hec.1353","article-title":"Globally optimal trial design for local decision making","volume":"18","author":"Eckermann","year":"2009","journal-title":"Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40273-013-0038-5","article-title":"Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharing","volume":"31","author":"Eckermann","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib75","first-page":"53","article-title":"Value of information analysis","volume":"2","author":"Claxton","year":"2014"},{"key":"10.1016\/j.jval.2020.01.001_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9","article-title":"An economic approach to clinical trial design and research priority-setting","volume":"5","author":"Claxton","year":"1996","journal-title":"Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib77","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/0272989X13501229","article-title":"Expected value of sample information for multi-arm cluster randomized trials with binary outcomes","volume":"34","author":"Welton","year":"2014","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13063-017-1934-3","article-title":"Comparative costs and activity from a sample of UK clinical trials units","volume":"18","author":"Hind","year":"2017","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.jval.2020.01.001_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40273-017-0572-7","article-title":"Research costs investigated: a study into the budgets of Dutch publicly funded drug-related research","volume":"36","author":"van Asselt","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.01.001_bib80","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jclinepi.2012.01.017","article-title":"Value of information methods for planning and analyzing clinical studies to optimize decision making and planning","volume":"65","author":"Willan","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jval.2020.01.001_bib81","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"issue":"7","key":"10.1016\/j.jval.2020.01.001_bib82","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hec.973","article-title":"Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty","volume":"14","author":"Al","year":"2005","journal-title":"Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2020.01.001_bib83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0272989X17746988","article-title":"Decision criterion and value of information analysis: optimal aspirin dosage for secondary prevention of cardiovascular events","volume":"38","author":"Basu","year":"2018","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jval.2017.04.011","article-title":"The impact of decision makers\u2019 constraints on the outcome of value of information analysis","volume":"21","author":"Koffijberg","year":"2018","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib85","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.socscimed.2004.06.038","article-title":"Assessing the benefits of health research: lessons from research into the use of antenatal corticosteroids for the prevention of neonatal respiratory distress syndrome","volume":"60","author":"Hanney","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jval.2020.01.001_bib86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0021-9681(85)90118-3","article-title":"Using economic analysis to determine the resource consequences of choices made in planning clinical trials","volume":"38","author":"Detsky","year":"1985","journal-title":"J.\u00a0Chronic Disease"},{"key":"10.1016\/j.jval.2020.01.001_bib87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/sim.4780090124","article-title":"Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials","volume":"9","author":"Detsky","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2020.01.001_bib88","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0277-9536(92)90128-D","article-title":"Assessing the costs and benefits of medical research: the diabetic retinopathy study","volume":"34","author":"Drummond","year":"1992","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jval.2020.01.001_bib89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0266462300016172","article-title":"Prioritising investments in health technology assessment: can we assess potential value for money?","volume":"16","author":"Davies","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"issue":"23","key":"10.1016\/j.jval.2020.01.001_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7230","article-title":"The role of modelling in prioritising and planning clinical trials","volume":"7","author":"Chilcott","year":"2003","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.jval.2020.01.001_bib91","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0272989X15614814","article-title":"Adjusting estimates of the expected value of information for implementation: theoretical framework and practical application","volume":"36","author":"Andronis","year":"2016","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2020.01.001_bib92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4733.2008.00431.x","article-title":"Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer","volume":"12","author":"Hoomans","year":"2009","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2020.01.001_bib93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0272989X16686766","article-title":"Assessing the expected value of research studies in reducing uncertainty and improving implementation dynamics","volume":"37","author":"Grimm","year":"2017","journal-title":"Med Decis Making"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:18:01Z","timestamp":1761095881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301520300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1098301520300279"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.01.001","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of Information Analysis for Research Decisions\u2014An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}